ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

NAS To Honor Outstanding Scientists

February 28, 1997

NCI Outlines Need For $3,873 Billion To Seize Cancer Research Opportunities

October 30, 1998

NCCN Admits Two New Member Institutions

March 22, 2013

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

AACR Journal Publishes a Henschke Letter Without Disclosure of Conflicts.

April 25, 2008